Skip to content
Companies

Pahtia Technologies

Tumor genomic testing for under-represented populations

Raised to date

$45K

of $50K offered across 1 Form D filing

Still open
$5K
Investors
5
Last filed
Mar 24, 2026

About

Pahtia Technologies Inc. (Pahtia Technologies) is a precision-oncology company headquartered in South Bend, Indiana that uses next-generation sequencing and artificial intelligence to widen access to cancer genomic profiling in populations under-represented in cancer research. Its Genomic Profile Test analyzes tumor DNA to identify genetic alterations that targeted therapies can act on, listed at $3,000 with a three-to-four-week turnaround, and is delivered through partnerships with local laboratories and hospitals rather than by shipping tissue abroad. The company is also building an AI-driven biomarker discovery platform on genomic data collected in these regions. It runs offices in South Bend and Guatemala City and has hospital partnerships in Panama and Guatemala, with Brazil, South Asia and Africa named as expansion markets.

Focuses on cancer genomics for populations largely absent from mainstream, European-derived research datasets, pricing profiling well below the $5,000-$10,000 typical cost and sequencing through local labs so patients do not need samples shipped internationally.

Funding

  • EquityFiled Mar 24, 2026Form D
    $45K/ $50K

Product

Genomic Profile Test

Genomic profiling / precision oncology testing

A tumor DNA analysis service that uncovers the specific genetic alterations in a patient's tumor which may be targeted by personalized therapies.

  • Tumor DNA sequencing revealing the tumor's genetic composition
  • Identification of potentially actionable targeted-therapy options
  • Report supporting oncologist treatment planning and clinical decisions

Built for

Oncologists, hospitals and cancer patients in Latin America (initially Panama, Guatemala and Brazil), with planned expansion into South Asia and Africa

People on file